Improved testing for adults with pneumonia who are not getting better
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether a more detailed genetic test of lung fluids can find the exact cause of pneumonia in people whose first treatment isn't working, and help doctors choose a more effective treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with community-acquired pneumonia (a lung infection you got outside a hospital)
- Your current pneumonia treatment has not helped you improve
- You have not already had this special genetic test (tNGS or mNGS) during this illness
- You are not bedridden and can care for yourself (for example, you can get out of bed and walk)
- You can provide a lung fluid sample (such as phlegm) for testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults who get pneumonia outside of a hospital (community-acquired pneumonia) to understand their symptoms, treatments, and outcomes. If you are an adult with this type of pneumonia, you might be able to join.
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
This study compares a newer, faster lab test (BioFire FilmArray) to standard testing for identifying the germs causing lung infections in hospitalized patients. The goal is to see if the faster test helps doctors choose better antibiotics more quickly.
Hear when a new Community Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.